Cancer concerns with topical immunomodulators in atopic dermatitis: overview of data and recommendations to clinicians.

Cancer concerns with topical immunomodulators in atopic dermatitis: overview of data and recommendations to clinicians.

Item
http://www.wikidata.org/entity/Q31119471
Topical tacrolimus for atopic dermatitisNonsteroidal Topical Immunomodulators in Allergology and DermatologyMurine atopic dermatitis responds to peroxisome proliferator-activated receptors alpha and beta/delta (but not gamma) and liver X receptor activators.Functional interpretation of metabolomics data as a new method for predicting long-term side effects: treatment of atopic dermatitis in infants.Oral epithelial dysplasia and squamous cell carcinoma following allogeneic hematopoietic stem cell transplantation: clinical presentation and treatment outcomesSystematic review of published trials: long-term safety of topical corticosteroids and topical calcineurin inhibitors in pediatric patients with atopic dermatitis.Topical tacrolimus with custom trays in the treatment of severe oral chronic graft-versus-host disease refractory to a potent topical steroid therapy: a case reportTacrolimus ointment: a novel and effective topical treatment of localized atopic dermatitis in a rhesus macaque (Macaca mulatta).Topical pimecrolimus 1% cream in the treatment of seborrheic dermatitis.Photocarcinogenicity of selected topically applied dermatological drugs: calcineurin inhibitors, corticosteroids, and vitamin D analogs.
P2860

Cancer concerns with topical immunomodulators in atopic dermatitis: overview of data and recommendations to clinicians.

Item
http://www.wikidata.org/entity/Q31119471
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Cancer concerns with topical i ...... recommendations to clinicians.
@ast
Cancer concerns with topical i ...... recommendations to clinicians.
@en
type
label
Cancer concerns with topical i ...... recommendations to clinicians.
@ast
Cancer concerns with topical i ...... recommendations to clinicians.
@en
prefLabel
Cancer concerns with topical i ...... recommendations to clinicians.
@ast
Cancer concerns with topical i ...... recommendations to clinicians.
@en
P1433
P1476
P2093
P2888
P304
P31
P356
P433
P478
P577
P6179
P698
P356
P1433
P1476
Cancer concerns with topical i ...... recommendations to clinicians.
@en
P2093
P2888
P304
P31
P356
10.2165/00128071-200708040-00001
P433
P478
P577
P6179
P698